Anatomy-Aware Effects of Biliopancreatic-Limb Length in Roux-en-Y Gastric Bypass: A Systematic Review and Meta-analysis
In brief
Two trials found no clear 5-point weight-loss gain from extending the bypass limb
In two trials involving 146 people, extending the biliopancreatic limb without changing the alimentary limb produced a 12-month weight-loss difference of just 0.36 percentage points, with results too uncertain to rule out smaller effects. Across the review, diabetes outcomes were sparse and varied by surgical configuration, so the isolated effect of limb length remains unclear.
- Journal
- Obesity surgery (Q1)
- Published
- 27 October 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Boyi Hu, Hua Meng
- PMID
- 42945023
- DOI
- 10.1007/s11695-026-08992-9
Why clinicians should know about it
- Picked for Bariatric and Metabolic Surgery (paper of the day, 28 October 2026): Bypass limb configuration and metabolic outcomes review
Abstract
Trials labelled "long" biliopancreatic limb (BPL) test different Roux-en-Y gastric bypass configurations. We separated fixed-alimentary-limb BPL extension, reciprocal limb reallocation, distalization, and compound changes. The registered primary outcome was 12-month HbA1c in baseline type 2 diabetes. Eighty reports represented 39 studies (14 randomized trials, 25 cohorts). Primary HbA1c differences were - 0.18% points (95% CI - 0.59 to + 0.23) for fixed-limb extension and - 0.33 (- 0.60 to - 0.06) for reallocation; these classes were not pooled. Two fixed-limb trials (146 participants) yielded a secondary 12-month percentage total weight-loss difference of + 0.36 points (- 0.60 to + 1.32). Glycemic evidence remains sparse and configuration-specific. Fixed-limb evidence is inconsistent with a 5-point weight-loss gain but does not exclude smaller effects or identify the isolated BPL effect. KEY POINTS: • Only three of 14 RCTs tested fixed-AL BPL extension; one measured the CC. • Primary 12-month HbA1c could not be pooled within an anatomical class. • Fixed-total reallocation suggested a modest HbA1c package effect. • Allocation shifts and distalization cannot identify an isolated BPL effect.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.